Affiliation:
1. Department of Pediatrics, St Luke's Regional Medical Center, Boise, Idaho
2. Department of Pediatrics, School of Medicine
3. Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland
4. Department of Patient Safety, Texas Tech University Health Sciences Center School of Nursing, Lubbock, Texas
Abstract
OBJECTIVES: We sought to describe pediatric cardiovascular medication errors and to determine patients and medications with more-frequently reported and/or more-harmful errors.
METHODS: We analyzed cardiovascular medication error reports from 2003–2004 for patients <18 years of age, from the US Pharmacopeia MEDMARX database. Reports were stratified according to harm score (A, near miss; B–D, error, no harm; E–I, harmful error). Proportions of harmful reports were determined according to drug class and age group. “High-risk” drugs were defined as antiarrhythmics, antihypertensives, digoxin, and calcium channel blockers.
RESULTS: A total of 147 facilities submitted 821 reports with community hospitals predominating (70%). Mean patient age was 4 years (median: 0.9 years). The most common error locations were NICUs, general care units, PICUs, pediatric units, and inpatient pharmacies. Drug administration, particularly improper dosing, was implicated most commonly. Severity analysis showed 5% “near misses,” 91% errors without harm, and 4% harmful errors, with no reported fatalities. A total of 893 medications were cited in 821 reports. Diuretics were cited most frequently, followed by antihypertensives, angiotensin inhibitors, β-adrenergic receptor blockers, digoxin, and calcium channel blockers. Calcium channel blockers, phosphodiesterase inhibitors, antiarrhythmics, and digoxin had the largest proportions of harmful events, although the values were not statistically significantly different from those for other drug classes. Infants <1 year of age accounted for 50% of reports. Proportions of harmful events did not differ according to age.
CONCLUSIONS: Infants <1 year of age were most frequently reported in cardiovascular medication errors reaching inpatients, in a national, voluntary, error-reporting database. Proportions of harmful errors were not significantly different by age or cardiovascular medication. Most errors were related to medication administration, largely due to improper dosing.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference29 articles.
1. Marino BL, Reinhardt K, Eichelberger WJ, Steingard R. Prevalence of errors in a pediatric hospital medication system: implications for error proofing. Outcomes Manag Nurs Pract. 2000;4(3):129–135
2. Crowley E, Williams R, Cousins D. Medication errors in children: a descriptive summary of medication error reports submitted to the United States Pharmacopeia. Curr Ther Res. 2001;62(9):627–640
3. Stucky ER; American Academy of Pediatrics, Committee on Drugs. Prevention of medication errors in the pediatric inpatient setting. Pediatrics. 2003;112(2):431–436
4. Institute for Safe Medication Practices. ISMP's list of high-alert medications. Available at: www.ismp.org/tools/highalertmedications.pdf. Accessed February 24, 2008
5. Litovitz T, Manoguerra A. Comparison of pediatric poisoning hazards: an analysis of 3.8 million exposure incidents: a report from the American Association of Poison Control Centers. Pediatrics. 1992;89(6):999–1006
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献